Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

TRPX

Therapix Biosciences (TRPX)

Therapix Biosciences Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:TRPX
DateTimeSourceHeadlineSymbolCompany
27/06/202306:05Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
21/06/202323:09Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
16/06/202323:09Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
12/06/202321:03Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
31/05/202306:02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
17/05/202320:02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
17/05/202307:31Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:TRPXTherapix Biosciences Ltd
08/05/202322:24Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
06/05/202306:01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
21/04/202323:13Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
05/04/202320:01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
04/04/202321:08Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
11/03/202309:02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
10/03/202308:16Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:TRPXTherapix Biosciences Ltd
28/02/202301:14Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
27/02/202323:47Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
17/02/202322:01Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-3)NASDAQ:TRPXTherapix Biosciences Ltd
17/02/202309:25Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
16/02/202300:35Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
26/01/202308:16Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
10/01/202308:02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
15/12/202208:02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
08/12/202205:09Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
30/11/202204:28Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
17/11/202208:04Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
08/11/202223:34Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
02/11/202207:01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
30/09/202221:28Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
17/09/202201:04Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
25/08/202220:56Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
 Showing the most relevant articles for your search:NASDAQ:TRPX